PharmaLectures.com

Courses › Pharma training by line of business › Week one at the finished-dose generic company: the company, the industry and Europe

Week one at the finished-dose generic company: the company, the industry and Europe

New hires pick the right procedure and fill the right record from their first week.

  • 10 audio modulesthree lengths each
  • 1 h 40 min to 8 h 20 minbriefing to expanded
  • Workbook, transcript, certificateand a recorded quiz per module
  • Finished-dose generic companywho it is written for

Why this training matters

In week one, a new starter in Supply Chain approves an active pharmaceutical ingredient supplier without a completed qualification file. The material stays in quarantine while Quality Assurance spends days tracing the missing paperwork. Production waits.

What changes after this course

Your team fills in batch records, qualifies suppliers and picks the European procedure without asking a colleague first. You hold a certificate for each learner and a training record per person to show the next inspector.

Watch the pitch

3:43 on how an audio course is bought, listened to and recorded. Full screen, one click.

Watch the pitch3:43, full screen, one click

What this course gives your people

The question about the Centralised or National route gets answered at the desk, not in a long email chain with Regulatory Affairs. Your new starter reads the scope of Regulation (EC) No 726/2004, knows that Decentralised and Mutual Recognition exist for multi-country filings, and sends the dossier the right way. The Common Technical Document is built in the right modules from the first draft.

Batch records reach Quality Assurance complete. Your team knows what EudraLex Volume 4, Chapter 4 expects from documentation, so missing signatures and gaps are caught at the line, not at release. When a deviation does happen, they write a Corrective and Preventive Action with a real root cause, and the same deviation stops coming back.

Active pharmaceutical ingredient suppliers are qualified before the first order, not after the first delivery. The coordinator opens the supplier file, checks it against the Quality Management System and European Good Manufacturing Practice Part II, and keeps the delivery in quarantine until the transport records are checked and Quality Assurance releases it.

In the buyer meeting, your sales representative answers the bioequivalence question in plain words, reads the award criteria of a tender under Directive 2014/24/EU, and prices to the local reimbursement rules. When a hospital contact hints at a favour, they know the company's anti-bribery rule and the Medicines for Europe code, and they decline politely.

Who needs this training

  • Quality Assurance Associate

    Reviewing a batch record late on a Thursday, they spot the missing signature and the gap against EudraLex Volume 4, Chapter 4, and send it back before the Qualified Person sees it.

  • Regulatory Affairs Specialist

    Starting a new filing, they choose between the Centralised, Decentralised, Mutual Recognition and National routes on the first read, and avoid filing in one country what needed several.

  • Supply Chain Coordinator

    Before a purchase order goes out, they open the supplier file, find what is missing and keep an unqualified active pharmaceutical ingredient source off the order.

  • European Sales Representative

    Walking into a hospital tender meeting, they know the award criteria, the local reimbursement rules and exactly where the line on gifts and hospitality sits.

  • Portfolio and Business Development Analyst

    When a patent nears expiry, they check for supplementary protection certificate extensions and tell the team the real earliest launch date, not the optimistic one.

Roles: every role in the company

Businesses: Finished-dose generic company

Countries: India, China, Türkiye, Korea, Japan, Taiwan, Egypt, Gulf and MENA, Brazil and Latin America, Pakistan, Bangladesh and Vietnam, United States, Europe

Selling into: Europe and the UK

Courses are in English. Other languages on request.

After this course your people can

  1. Write a Corrective and Preventive Action plan with a stated root cause and an effectiveness check.
  2. Choose between the Centralised and National procedure for a new generic and state the reason in one sentence.
  3. Check a supplier qualification file for the gaps a Qualified Person would stop on.
  4. Find the missing entries in a batch record by checking it against EudraLex Volume 4, Chapter 4.
  5. Read a public tender notice and list its award criteria before pricing a single line.
  6. Decline a gift or favour from a buyer and record it under the company's anti-bribery procedure.
  7. Name the earliest realistic launch date for a generic by checking patent and supplementary protection certificate status.

What the company gets

  • Regulatory submissions go out on the right procedure the first time, so a filing is not repeated in another country.
  • Batch records reach Quality Assurance complete, and closed deviations sit in the file when an inspector asks for them.
  • Supplier files are complete before the first order, so a delivery is not held in quarantine for missing paperwork.
  • Sales staff have a clear, recorded answer on gifts, hospitality and tender conduct that you can show a buyer or an auditor.
  • You hold a certificate for each learner and a training record per person, ready for the next inspection.

The evidence: questionnaire, training record, certificate

EU GMP Chapter 2, section 2.11, and 21 CFR 211.25 both ask for training that is documented and shown to work. This is what each learner leaves behind.

A recorded questionnaire per module

Every one of the 10 modules ends with a multiple-choice questionnaire. The result is recorded per person with a timestamp, whichever of the three lengths the person listened to.

A per-person training record

The export lists each learner, each module, the result and the date, which is the training record EU GMP Chapter 2 and 21 CFR 211.25 ask you to keep and the first thing an inspector asks for.

A certificate per learner

Name, company, course, hours, the guideline version taught and the date. It documents in-company training; it is not a professional qualification or an accreditation.

Your pass mark, your rule

There is no fixed pass mark. Your quality or human-resources manager decides what counts as passed and when a module is retaken, exactly as your training procedure says.

Delivered within 72 hours of payment, with the workbook, the full transcript and a source for every fact in the audio.

How long it takes, by who is listening

Nobody spends a day in a classroom. Every module exists in three lengths; a person takes the length their role needs, and every length ends with the same recorded questionnaire, so the training record is complete either way.

Briefing1 h 40 min10 min a module, for executives, sales and anyone who must know the rules, not run them
Standard4 h 10 min25 min a module, for regulatory, quality and business-development staff
Expanded8 h 20 min50 min a module, for technical staff who run the procedure day to day
Who takes this courseLengthTotal time
Owner, CEO and boardBriefing1 h 40 min
Business development and export salesBriefing1 h 40 min
Finance, pricing and tendersBriefing1 h 40 min
Marketing and communicationsBriefing1 h 40 min
Human resources and onboardingBriefing1 h 40 min
IT, data and validationBriefing1 h 40 min
Regulatory affairsStandard4 h 10 min
Quality assurance and Qualified PersonStandard4 h 10 min
Quality control and laboratoryStandard4 h 10 min
Production and engineeringStandard4 h 10 min
Supply chain, purchasing and logisticsStandard4 h 10 min
Pharmacovigilance and medicalStandard4 h 10 min

Course outline: 10 modules

10 modules. Under each title are the three things the listener can do afterwards; the audio itself runs 10 to 50 minutes depending on the length chosen.

  1. 1Show buyers why your generic is bioequivalent and worth its price

    • How to answer a buyer's bioequivalence question without repeating the originator's trials.
    • Why a health system cares about the price gap between your generic and the reference product.
    • What to say when a pharmacist asks whether a generic works as well as the brand.
  2. 2Read patent expiry dates to predict when a generic can enter a market

    • Why the patent expiry date is not always your launch date: supplementary protection certificates.
    • How to time your dossier work so approval lands when protection ends, not months after.
    • The line between a finished-dose generic and a biosimilar, and why our portfolio sits on one side.
  3. 3Place your daily tasks in our therapeutic areas and reporting lines

    • Where your own job sits among our therapeutic areas, so you know whose product you touch.
    • How to send a decision to the right reporting line the first time, not the third.
    • Who to ask when a question crosses two departments, and what to bring with you.
  4. 4Follow a finished-dose product from dossier submission to market withdrawal

    • Which of the five Common Technical Document modules holds which file, so nothing is misfiled.
    • Why safety reporting duties begin the day the licence is granted, not at first sale.
    • What forces a variation filing when your active substance source changes, and who files it.
  5. 5Choose Centralised or National procedure for a European application

    • How to tell whether a product must go Centralised, using the scope in Regulation (EC) No 726/2004.
    • Why one Centralised approval from the European Commission covers every member state at once.
    • When a National procedure fits a single-country launch, and when it forces repeat filings.
  6. 6Apply European Good Manufacturing Practice to keep the line running

    • How to spot a deviation in your own area before an inspector does.
    • What EudraLex Volume 4, Chapter 4 expects from your documents when an inspector asks to see them.
    • When a quality defect must be reported under Chapter 8, and who receives the report.
  7. 7Draft Corrective and Preventive Actions for your Quality Management System

    • Why retraining the operator is rarely a root cause, and what to write instead.
    • How a correction, a corrective action and a preventive action differ, with one example each.
    • What to put in a Corrective and Preventive Action plan so its effectiveness check passes.
  8. 8Qualify active pharmaceutical ingredient suppliers to protect supply

    • How to qualify an active pharmaceutical ingredient supplier so the Qualified Person can sign.
    • What a supplier file must hold before the first order, and what an auditor looks for in it.
    • What to check on the transport records before delivered material leaves quarantine.
  9. 9Win public procurement tenders with a generic pricing strategy

    • How to read a tender notice and find the award criteria before you price a single line.
    • Why the most economically advantageous tender is not always the lowest price.
    • The reimbursement rules in each country that change the price you can offer.
  10. 10Apply anti-bribery rules in market access negotiations

    • What to do when a hospital buyer offers a favour or asks for one during a negotiation.
    • When a gift or a dinner fits the Medicines for Europe code of conduct, and when it does not.
    • How to record a tender conversation so nobody questions it later.
The founders

One of us was inspected. The other one pays for the training.

Every claim below is sourced on the about page: the medicines register, the Lithuanian Pharmaceutical Union board list, the university directory.

Justina Krukonytė-Racz

Justina Krukonytė-Racz

Co-founder. Licensed pharmacist.

GDPResponsible PersonWarehouse & logistics

Licensed pharmacist. Responsible Person at Tamro (PHOENIX group), where she led the GDP set-up of the distribution centre.

The Responsible Person is the named person the regulator holds accountable for every pallet that leaves the building.

She writes the modules around the procedures a GDP inspection checks. Board member of Lithuanian Pharmaceutical Union.

Listed in the Lithuanian medicines register as Pharmacist.

Prof. Ben Racz

Prof. Ben Racz

Co-founder. Builds the platform and is responsible for delivery, records and pricing.

Platform & deliveryQuantitative researchCarnegie Mellon

He was Professor of the Practice at the College of Engineering at Carnegie Mellon University, where he taught Advanced Quantitative Finance and Algorithmic Trading to MSc students.

He is the founder and Managing Director of Algorithmic Sciences, a scientific research and consulting firm. Earlier he co-founded a data-driven growth consultancy, a data-science based wholesale trading company and an information security firm.

More about Ben at benracz.com

Questions about this course

Is there a certificate?

Yes. Every learner who finishes the course receives a certificate in their own name, and every module ends with a recorded multiple-choice questionnaire, so the certificate sits on top of a per-person training record. The certificate documents in-company training; it is not a professional qualification or an accreditation, and your quality or human-resources manager sets the pass mark and decides when a module is retaken.

How long does the course take?

10 modules, each in three lengths: a 10-minute briefing, a 25-minute standard run and a 50-minute expanded walk-through. The whole course takes 1 h 40 min in the briefing length and 8 h 20 min in the expanded length. People take the length their role needs, and every length ends with the same recorded questionnaire, so the training record is complete either way.

Who should take this course?

It is written for Finished-dose generic company. Owners, managers and sales staff hear the briefing length, regulatory, quality and business-development staff take the standard run, and the people who run the procedure every day get the expanded version. One licence covers one named person on this course for a year, so the same title can be rolled out across a whole team at once.

Is this training accepted as a GMP training record by an auditor?

EU GMP Chapter 2 and 21 CFR 211.25 require documented, effective training, and that is what the course produces: a recorded multiple-choice result per module and per person, a certificate per learner and a transcript of what was taught. No provider can promise acceptance by a specific inspector; the record is built to answer what inspectors ask for, and your quality manager decides the pass mark.

How is it delivered and how fast?

The course arrives as audio files with a companion workbook, a full transcript and the questionnaire per module, within 72 hours of your payment arriving. You host the files on your own system or share them as you like; there is no platform to log into and no learner management system to set up. The free sample module arrives on request, before any purchase.

What does it cost per learner?

The list price is 9 euros per module, per learner, per year, so this course is 90 euros for one person for twelve months. The price per learner falls as more people take the same course: 10 learners pay 10 percent less and the discount keeps growing to 50 percent at 1000 learners. Type a number on the price panel and the yearly total appears.

Get this course for your team

One licence is one person on this course for a year. All three lengths, the workbook, the certificate and the training record are included in every purchase. Pick how many people, add it to the cart, and you have an invoice in your inbox.

Free sample module

Hear one full module before you spend a cent. Send your company and the role you want trained, and a complete sample module comes back with its workbook and transcript.

Connect on WhatsApp

or email [email protected], or ask for a written quote for your team